Brent Sabatini

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brent Sabatini:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. SVP, Chief Accounting Officer Common Stock 71,043 $529,469 $7.45 23 Feb 2026 Direct
Vir Biotechnology, Inc. SVP, Chief Accounting Officer Stock Option (Right to Buy) 50,000 $61,200 $1.53 22 Feb 2026 Direct

Insider Reports Filed by Brent Sabatini

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIR Vir Biotechnology, Inc. 22 Feb 2026 3 -$13,631 4 SVP, Chief Accounting Officer 24 Feb 2026, 19:13
VIR Vir Biotechnology, Inc. 13 Feb 2026 1 -$11,919 4 SVP, Chief Accounting Officer 18 Feb 2026, 15:38
VIR Vir Biotechnology, Inc. 22 Feb 2025 3 -$14,766 4 SVP, Chief Accounting Officer 25 Feb 2025, 15:37
VIR Vir Biotechnology, Inc. 13 Feb 2025 1 -$14,291 4 SVP, Chief Accounting Officer 14 Feb 2025, 18:41
VIR Vir Biotechnology, Inc. 01 Oct 2024 0 $0 3 SVP, Chief Accounting Officer 02 Oct 2024, 12:09